These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 11079151)

  • 21. Radio-labeled receptor-binding peptides: a new class of radiopharmaceuticals.
    Boerman OC; Oyen WJ; Corstens FH
    Semin Nucl Med; 2000 Jul; 30(3):195-208. PubMed ID: 10928383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Radiolabeled peptides in oncology: role in diagnosis and treatment.
    Weiner RE; Thakur ML
    BioDrugs; 2005; 19(3):145-63. PubMed ID: 15984900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of a radiolabelled cyclic DTPA-RGD analogue for tumour imaging and radionuclide therapy.
    van Hagen PM; Breeman WA; Bernard HF; Schaar M; Mooij CM; Srinivasan A; Schmidt MA; Krenning EP; de Jong M
    Int J Cancer; 2000 Aug; 90(4):186-98. PubMed ID: 10993959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Radiolabeled peptides in the diagnosis and therapy of oncological diseases.
    Weiner RE; Thakur ML
    Appl Radiat Isot; 2002 Nov; 57(5):749-63. PubMed ID: 12433051
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rhenium-188: availability from the (188)W/(188)Re generator and status of current applications.
    Pillai MR; Dash A; Knapp FF
    Curr Radiopharm; 2012 Jul; 5(3):228-43. PubMed ID: 22642385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptor-mediated tumor targeting with radiolabeled peptides: there is more to it than somatostatin analogs.
    Mariani G; Erba PA; Signore A
    J Nucl Med; 2006 Dec; 47(12):1904-7. PubMed ID: 17138731
    [No Abstract]   [Full Text] [Related]  

  • 27. Chelating systems for (99m)Tc/(188)Re in the development of radiolabeled peptide pharmaceuticals.
    Bolzati C; Carta D; Salvarese N; Refosco F
    Anticancer Agents Med Chem; 2012 Jun; 12(5):428-61. PubMed ID: 22292757
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radiolabeled peptides in diagnosis and therapy.
    Weiner RE; Thakur ML
    Semin Nucl Med; 2001 Oct; 31(4):296-311. PubMed ID: 11710772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiopharmaceuticals for targeted radiotherapy.
    Marques F; Paulo A; Campello MP; Lacerda S; Vitor RF; Gano L; Delgado R; Santos I
    Radiat Prot Dosimetry; 2005; 116(1-4 Pt 2):601-4. PubMed ID: 16604708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radiotargeted gene therapy.
    Buchsbaum DJ; Chaudhuri TR; Zinn KR
    J Nucl Med; 2005 Jan; 46 Suppl 1():179S-86S. PubMed ID: 15653667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dosimetry and optimization of in vivo targeting with radiolabeled antisense oligodeoxynucleotides: oligonucleotide radiotherapy.
    Kairemo KJ; Jekunen AP; Tenhunen M
    Methods Enzymol; 2000; 314():506-24. PubMed ID: 10565036
    [No Abstract]   [Full Text] [Related]  

  • 32. Radiolabelled apoptotic probe may be a vehicle for a novel multimodality radionuclide tumour therapy.
    Dizdarevic S; McCready R; Turner JF; Bagley MC; Blower P; Schmid P; Flux G; Hall A; Ziv I
    Eur J Nucl Med Mol Imaging; 2014 Jun; 41(6):1255-6. PubMed ID: 24566950
    [No Abstract]   [Full Text] [Related]  

  • 33. Proceedings of the 1st International Symposium on Radionuclide Therapy and Radiopharmaceutical Dosimetry. September 4-8, 2004, Helsinki, Finland.
    Cancer Biother Radiopharm; 2005 Feb; 20(1):41-118. PubMed ID: 15778578
    [No Abstract]   [Full Text] [Related]  

  • 34. Rhenium-188--a generator-derived radioisotope for cancer therapy.
    Knapp FF
    Cancer Biother Radiopharm; 1998 Oct; 13(5):337-49. PubMed ID: 10851424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Radiolabeled peptide conjugates for targeting of the bombesin receptor superfamily subtypes.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2005 Oct; 32(7):733-40. PubMed ID: 16243649
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeted alpha therapy with 213Bi.
    Morgenstern A; Bruchertseifer F; Apostolidis C
    Curr Radiopharm; 2011 Oct; 4(4):295-305. PubMed ID: 22202152
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The bright future of radionuclides for cancer therapy.
    Nijsen JF; Krijger GC; van Het Schip AD
    Anticancer Agents Med Chem; 2007 May; 7(3):271-90. PubMed ID: 17504155
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gastrin releasing peptide (GRP) receptor targeted radiopharmaceuticals: a concise update.
    Smith CJ; Volkert WA; Hoffman TJ
    Nucl Med Biol; 2003 Nov; 30(8):861-8. PubMed ID: 14698790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radiometallated peptides for molecular imaging and targeted therapy.
    Correia JD; Paulo A; Raposinho PD; Santos I
    Dalton Trans; 2011 Jun; 40(23):6144-67. PubMed ID: 21350775
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroendocrine tumours treated with mIBG and radiolabeled peptides].
    Giammarile F; Borson-Chazot F
    Pathol Biol (Paris); 2006 Apr; 54(3):130-6. PubMed ID: 16084027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.